Adam R. Craig
2017
In 2017, Adam R. Craig earned a total compensation of $5.6M as President and Chief Executive Officer at CTI BioPharma.
Compensation breakdown
| Bonus | $382,500 |
|---|---|
| Option Awards | $4,453,440 |
| Salary | $433,653 |
| Other | $298,396 |
| Total | $5,567,989 |
Craig received $4.5M in option awards, accounting for 80% of the total pay in 2017.
Craig also received $382.5K in bonus, $433.7K in salary and $298.4K in other compensation.
Rankings
In 2017, Adam R. Craig's compensation ranked 1,622nd out of 14,666 executives tracked by ExecPay. In other words, Craig earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,622 out of 14,666 | 89th |
Division Manufacturing | 541 out of 5,772 | 91st |
Major group Chemicals And Allied Products | 143 out of 2,075 | 93rd |
Industry group Drugs | 104 out of 1,731 | 94th |
Industry Pharmaceutical Preparations | 83 out of 1,333 | 94th |
Source: SEC filing on March 30, 2018.
Craig's colleagues
We found six more compensation records of executives who worked with Adam R. Craig at CTI BioPharma in 2017.
2017
Bruce Seeley
CTI BioPharma
Chief Operating Officer
2017
Jack Singer
CTI BioPharma
Chief Scientific Officer
2017
David Kirske
CTI BioPharma
Chief Financial Officer
2017
Louis Bianco
CTI BioPharma
Former Executive Vice President, Finance and Administration
2017
Matthew Plunkett
CTI BioPharma
Former Executive Vice President, Chief Business Officer
2017
Richard Love
CTI BioPharma